Grantclosed🌐 United StatesPA-25-169

Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Jan 8, 2025
Response deadline: May 7, 2026, 12:00 AM UTC
Type: Grant
Category: 93.867, 93.286, 93.866
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PA-25-169

Doc Type: synopsis

Similar past solicitations

Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
United States · Apr 24, 2023
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
United States · Dec 9, 2024
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
United States · Nov 15, 2024
NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)
United States · Aug 5, 2025
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
United States · Jun 12, 2025
DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award
United States · Apr 22, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.